Harry W. Hind, a 1939 graduate of the UCSF School of Pharmacy who invented solutions that revolutionized contact lens use, as well as a topical patch to treat pain from shingles, died on April 12 at age 96.
Hind co-founded Barnes-Hind Pharmaceuticals Inc., which developed drugs to treat tuberculosis and glaucoma. He was...
Speaking on a White House panel discussing President Obama's just-released Bioeconomy Blueprint, UCSF Vice Chancellor for Research Keith Yamamoto, PhD, cited the implantable bioartificial kidney project led by UCSF bioengineer Shuvo Roy, PhD, as a prime example of biomedical collaboration with potentially major...
From the start of his illustrious half-century career in mass spectrometry, Al Burlingame, PhD, has been part of a scientific sea change.
In his first lab at UC Berkeley, complete with a dirt floor and leaky roof, he looked for signs of extraterrestrial life in meteorites. He compares an earlier mass spectrometry...
New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Clinical Pharmacy:
Malaria treatment for HIV-positive children and pregnant women Francesca Aweeka, PharmD Professor in residence Awarded $579,350...New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included a half-dozen on-going projects by BTS faculty:
Genetic mutations and liver cancer Xin Chen, PhD Associate adjunct professor Awarded two new grants totaling $351,488 from the National Institute of...
For the 32nd consecutive year, the UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.
Total grants and contracts awarded to School of Pharmacy researchers during the NIH fiscal year 2011 (running from October 1, 2010 to...
New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Pharmaceutical Chemistry:
Precisely targeting malaria parasites with drugs Adam Renslo, PhD Associate director of chemistry for the department-...
UCSF bioengineer Tejal Desai, PhD, will receive the 2012 Paul R. Dawson Biotechnology Award from the American Association of Colleges of Pharmacy (AACP) at the group’s annual meeting in July.
The award honors Desai for her contributions to contemporary teaching and scholarship in biotechnology. She is a faculty member...
The effort led by UCSF bioengineer Shuvo Roy, PhD, to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the U.S. Food and Drug Administration (FDA).
The FDA announced on April 9, 2012 that it had chosen three...